CMAB Biopharma
Exclusively focused on delivering fully integrated CDMO services for biologics
Founded 2017
Suzhou, China
38 employees
Series B
Total: $72.00M
Biopharma, Biotechnology +1
Suzhou, China
38 employees
Series B
Total: $72.00M
Biopharma, Biotechnology +1
General Information
Get notified when CMAB Biopharma moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track CMAB Biopharma
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
China Market
Biopharma
About CMAB Biopharma
Taxonomy: CDMO, Biologics, Biopharmaceuticals, Monoclonal Antibody, Biosimilars, cGMP, Contract Development and Manufacturing Organization, Process Development, Manufacturing Services, Preclinical Drug Development, Clinical Drug Development, DNA Sequences, GMP Standards, BioBAY Park
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | •••••• | 5 |
|
02 Apr 2018 |
| Series A | •••••• | 3 |
|
02 Jan 2018 |
CMAB Biopharma Alternatives & Competitors
CMAB Biopharma vs
Everest Medicines
United States
Better Medicines, Better Life
IPO
157 employees
Biotechnology, Health Care
CMAB Biopharma vs
Innovent Biologics
China
To develop and commercialize high-quality biopharmaceuticals that are affordable to ordinary people
Post Ipo Equity
846 employees
Biopharma, Biotechnology
FAQ About CMAB Biopharma
Exclusively focused on delivering fully integrated CDMO services for biologics
CMAB Biopharma was founded in 2017.
CMAB Biopharma is headquartered in Suzhou, China.
CMAB Biopharma operates in the following industries: Biopharma, Biotechnology, Manufacturing.
CMAB Biopharma has approximately 38 employees.
CMAB Biopharma has completed 2 funding rounds, raising a total of $72.00M. The latest funding stage is Series B.
Top alternatives and competitors to CMAB Biopharma include Everest Medicines, Innovent Biologics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CMAB Biopharma and Everest Medicines are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors CMAB Biopharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.